Lilly to seek accelerated FDA approval for Alzheimer's drug this year

6 monate vor

Eli Lilly said on Thursday it will apply for U.S. health regulator's accelerated approval this year for its experimental Alzheimer's drug, weeks after Biogen Inc's (BIIB.O) controversial drug for the disease was approved. #EliLilly #Alzheimer #FDA #News #Reuters Subscribe: Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram:
Aus der Quelle lesen